An Observational Study of Patients Living With Chronic Neurological Diseases

Target PharmaSolutions

Status

Not yet enrolling

Conditions

Alzheimer Disease

Dementia of Alzheimer Type

Multiple Sclerosis

Mild Cognitive Impairment

Parkinson Disease

Neurological Diseases or Conditions

Study type

Observational

Funder types

Industry

Identifiers

NCT05796037

TARGET-NEURO

Details and patient eligibility

About

TARGET-NEURO is an observational research study to conduct a comprehensive review of outcomes for patients living with chronic neurological diseases: Alzheimer's disease and related dementia (ADRD), mild cognitive impairment (MCI), Parkinson's disease (PD), and multiple sclerosis (MS).

Enrollment

1,500,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Disease Cohort

Inclusion Criteria:

•Adult patients at the time of enrollment with a diagnosis of ADRD, MCI, PD, or MS by select ICD-10 codes in the EHR interface

Exclusion Criteria:

Death
Manual removal (sponsor or site request)
No EHR interface encounter > 3 years

Engaged Cohort

Inclusion Criteria:

Adult patients diagnosed and managed for these conditions invited to participate
Ability to provide written informed consent (or have a legally authorized representative to provide informed consent)
Care partners may be invited to participate in surveys and will provide informed consent.

Exclusion Criteria:

Patient expressed desire to withdraw consent to complete PROs
Care partner expressed desire to withdraw consent to complete PROs
Failure to complete PROs within 24 weeks of initial invitation
Greater than 24 months lapse of survey completion after baseline surveys completed
Additionally, the criteria detailed for Disease Cohort apply to the Engaged Cohort

Age Cohort

Inclusion Criteria:

•Adult patients aged 60 and older at time of enrollment

Exclusion Criteria: